Development of an XBP1 agonist, HLJ2, as a potential therapeutic agent for ulcerative colitis

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Development of an XBP1 agonist, HLJ2, as a potential therapeutic agent for ulcerative colitis
Authors
Keywords
Ulcerative colitis, XBP1, Intestinal flora, Intestinal mucosa, Cytokines
Journal
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 109, Issue -, Pages 56-64
Publisher
Elsevier BV
Online
2017-07-28
DOI
10.1016/j.ejps.2017.07.028

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.